Bayforest Capital’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
Bayforest Capital's ADPT Position: Q2 2026 in Review
Bayforest Capital reduced its Adaptive Biotechnologies (ADPT) stake by 82% in Q2 2026, selling an estimated $104K and leaving 1,504 shares worth $32.3K. The position accounts for 0.03% of the portfolio, ranked #727.
Bayforest Capital first reported a position in ADPT in Q4 2025 and has held it in 3 quarters since. The position peaked at $142K in Q4 2025. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.
- Bayforest Capital held 1,504 shares of Adaptive Biotechnologies worth $32.3K as of Q2 2026.
- Bayforest Capital sold 6,786 Adaptive Biotechnologies shares in Q2 2026, an estimated $104K.
- Adaptive Biotechnologies made up 0.03% of Bayforest Capital's portfolio in Q2 2026, its #727 holding.
- Bayforest Capital first reported a position in Adaptive Biotechnologies in Q4 2025 and has held it in 3 quarters since.
- Bayforest Capital's Adaptive Biotechnologies position peaked at $142K in Q4 2025.
- 301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.
Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.